New clinical and experimental insights into Old World and neotropical ocular toxoplasmosis

International Journal for Parasitology

Volumn 44, Issue 2, 2014, Pages 99-107

  Pfaff, Alexander W ^a   de la Torre, Alejandra ^a,b,d   Rochet, Elise ^a   Brunet, Julie ^a   Sabou, Marcela ^a   Sauer, Arnaud ^c   Bourcier, Tristan ^c   Gomez Marin, Jorge E ^b   Candolfi, Ermanno ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSIDAD DEL QUINDÍO   (Colombia)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

Human studies; Inflammation; Mouse models; Ocular toxoplasmosis; Parasite strains; South America; Toxoplasma gondii

Indexed keywords

DISEASE; GENE; GENETIC MARKER; PARASITE; PARASITE TRANSMISSION; PROTEIN; PROTOZOAN; VIRULENCE;

EUROPE; GENETIC MARKER; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HOST PARASITE INTERACTION; HOST SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; NONHUMAN; NORTH AMERICA; PARASITE INCIDENCE; PARASITE LOAD; PARASITE PREVALENCE; PARASITE VIRULENCE; PATHOPHYSIOLOGY; REVIEW; SOUTH AMERICA; TOXOPLASMOSIS;

SOUTH AMERICA;

PROTOZOA; TOXOPLASMA GONDII;

HUMAN STUDIES; INFLAMMATION; MOUSE MODELS; OCULAR TOXOPLASMOSIS; PARASITE STRAINS; SOUTH AMERICA; TOXOPLASMA GONDII;

AMERICAS; ANIMALS; EUROPE; EYE DISEASES; HUMANS; TOXOPLASMOSIS;

EID: 84892499165     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2013.09.007     Document Type: Review

References (106)

1. Ajzenberg D. Unresolved questions about the most successful known parasite. Expert Rev. Anti Infect. Ther. 2011, 9:169-171.
2. Albuquerque M.C., Aleixo A.L., Benchimol E.I., Leandro A.C., das Neves L.B., Vicente R.T., Bonecini-Almeida Mda G., Amendoeira M.R. The IFN-gamma +874T/A gene polymorphism is associated with retinochoroiditis toxoplasmosis susceptibility. Mem. Inst. Oswaldo Cruz 2009, 104:451-455.
3. Barisani-Asenbauer T., Maca S.M., Mejdoubi L., Emminger W., Machold K., Auer H. Uveitis- a rare disease often associated with systemic diseases and infections- a systematic review of 2619 patients. Orphanet J Rare Dis. 2012, 7:57.
4. Bosch-Driessen L.E., Berendschot T.T., Ongkosuwito J.V., Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 2002, 109:869-878.
5. Bringmann A., Pannicke T., Grosche J., Francke M., Wiedemann P., Skatchkov S.N., Osborne N.N., Reichenbach A. Muller cells in the healthy and diseased retina. Prog. Retin. Eye Res. 2006, 25:397-424.
6. Brunet J., Pfaff A.W., Abidi A., Unoki M., Nakamura Y., Guinard M., Klein J.P., Candolfi E., Mousli M. Toxoplasma gondii exploits UHRF1 and induces host cell cycle arrest at G2 to enable its proliferation. Cell. Microbiol. 2008, 10:908-920.
7. Burnett A.J., Shortt S.G., Isaac-Renton J., King A., Werker D., Bowie W.R. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 1998, 105:1032-1037.
8. Butler N.J., Furtado J.M., Winthrop K.L., Smith J.R. Ocular toxoplasmosis II: clinical features, pathology and management. Clin. Exp. Ophthalmol. 2013, 41:95-108.
9. Caspi R. Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells. Immunol. Res. 2008, 42:41-50.
10. Caspi R.R. Ocular autoimmunity: the price of privilege?. Immunol. Rev. 2006, 213:23-35.
11. Charles E., Callegan M.C., Blader I.J. The SAG1 Toxoplasma gondii surface protein is not required for acute ocular toxoplasmosis in mice. Infect. Immun. 2007, 75:2079-2083.
12. Charles E., Joshi S., Ash J.D., Fox B.A., Farris A.D., Bzik D.J., Lang M.L., Blader I.J. CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1. Infect. Immun. 2010, 78:3484-3492.
13. Chen Y., Yang P., Li F., Kijlstra A. The effects of Th17 cytokines on the inflammatory mediator production and barrier function of ARPE-19 cells. PLoS ONE 2011, 6:e18139.
14. Chen Y., Sawada O., Kohno H., Le Y.Z., Subauste C., Maeda T., Maeda A. Autophagy protects the retina from light-induced degeneration. J. Biol. Chem. 2013, 288:7506-7518.
15. Cimino L., Aldigeri R., Salvarani C., Zotti C.A., Boiardi L., Parmeggiani M., Casali B., Cappuccini L. The causes of uveitis in a referral centre of Northern Italy. Int. Ophthalmol. 2010, 30:521-529.
16. Cordeiro C.A., Moreira P.R., Andrade M.S., Dutra W.O., Campos W.R., Orefice F., Teixeira A.L. Interleukin-10 gene polymorphism (-1082G/A) is associated with toxoplasmic retinochoroiditis. Invest. Ophthalmol. Vis. Sci. 2008, 49:1979-1982.
17. Cordeiro C.A., Moreira P.R., Costa G.C., Dutra W.O., Campos W.R., Orefice F., Teixeira A.L. TNF-alpha gene polymorphism (-308G/A) and toxoplasmic retinochoroiditis. Br. J. Ophthalmol. 2008, 92:986-988.
18. Cordeiro C.A., Moreira P.R., Costa G.C., Dutra W.O., Campos W.R., Orefice F., Teixeira A.L. Interleukin-1 gene polymorphisms and toxoplasmic retinochoroiditis. Mol. Vis. 2008, 14:1845-1849.
19. Cordeiro C.A., Moreira P.R., Bessa T.F., Costa G.C., Dutra W.O., Campos W.R., Orefice F., Young L.H., Teixeira A.L. Interleukin-6 gene polymorphism (-174 G/C) is associated with toxoplasmic retinochoroiditis. Acta Ophthalmol. 2013, 91:e311-314.
20. Davidson M.G., Lappin M.R., English R.V., Tompkins M.B. A feline model of ocular toxoplasmosis. Invest. Ophthalmol. Vis. Sci. 1993, 34:3653-3660.
21. De-la-Torre A., Gonzalez G., Diaz-Ramirez J., Gomez-Marin J.E. Screening by ophthalmoscopy for Toxoplasma retinochoroiditis in Colombia. Am. J. Ophthalmol. 2007, 143:354-356.
22. De-la-Torre A., Rios-Cadavid A.C., Cardozo-Garcia C.M., Gomez-Marin J.E. Frequency and factors associated with recurrences of ocular toxoplasmosis in a referral centre in Colombia. Br. J. Ophthalmol. 2009, 93:1001-1004.
23. De-la-Torre A., Gonzalez-Lopez G., Montoya-Gutierrez J.M., Marin-Arango V., Gomez-Marin J.E. Quality of life assessment in ocular toxoplasmosis in a Colombian population. Ocul. Immunol. Inflamm. 2011, 19:262-266.
24. De-la-Torre, A., Sauer, A., Pfaff, A.W., Bourcier, T., Brunet, J., Speeg-Schatz, C., Ballonzoli, L., Villard, O., Ajzenberg, D., Sundar, N., Grigg, M.E., Gomez-Marin, J.E., Candolfi, E., 2013. Severe South American ocular toxoplasmosis is associated with decreased IFN-gamma/IL-17A and increased IL-6/IL-13 intraocular levels. PLoS Negl. Trop. Dis. (in press).
25. de Moura L., Bahia-Oliveira L.M., Wada M.Y., Jones J.L., Tuboi S.H., Carmo E.H., Ramalho W.M., Camargo N.J., Trevisan R., Graca R.M., da Silva A.J., Moura I., Dubey J.P., Garrett D.O. Waterborne toxoplasmosis, Brazil, from field to gene. Emerg. Infect. Dis. 2006, 12:326-329.
26. Delair E., Monnet D., Grabar S., Dupouy-Camet J., Yera H., Brezin A.P. Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis. Am. J. Ophthalmol. 2008, 146:851-855.
27. Delair E., Latkany P., Noble A.G., Rabiah P., McLeod R., Brezin A. Clinical manifestations of ocular toxoplasmosis. Ocul. Immunol. Inflamm. 2011, 19:91-102.
28. Dodds E.M., Holland G.N., Stanford M.R., Yu F., Siu W.O., Shah K.H., Ten Dam-van Loon N., Muccioli C., Hovakimyan A., Barisani-Asenbauer T. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am. J. Ophthalmol. 2008, 146(856-865):e852.
29. Dutra M.S., Bela S.R., Peixoto-Rangel A.L., Fakiola M., Cruz A.G., Gazzinelli A., Quites H.F., Bahia-Oliveira L.M., Peixe R.G., Campos W.R., Higino-Rocha A.C., Miller N.E., Blackwell J.M., Antonelli L.R., Gazzinelli R.T. Association of a NOD2 Gene Polymorphism and T-Helper 17 Cells With Presumed Ocular Toxoplasmosis. J. Infect. Dis. 2013, 207:152-163.
30. Fekkar A., Ajzenberg D., Bodaghi B., Touafek F., Le Hoang P., Delmas J., Robert P.Y., Darde M.L., Mazier D., Paris L. Direct genotyping of Toxoplasma gondii in ocular fluid samples from 20 patients with ocular toxoplasmosis: predominance of type II in France. J. Clin. Microbiol. 2011, 49:1513-1517.
31. Fischer H.G., Nitzgen B., Reichmann G., Gross U., Hadding U. Host cells of Toxoplasma gondii encystation in infected primary culture from mouse brain. Parasitol. Res. 1997, 83:637-641.
32. Furtado J.M., Bharadwaj A.S., Chipps T.J., Pan Y., Ashander L.M., Smith J.R. Toxoplasma gondii tachyzoites cross retinal endothelium assisted by intercellular adhesion molecule-1 in vitro. Immunol. Cell Biol. 2012, 90:912-915.
33. Furtado J.M., Winthrop K.L., Butler N.J., Smith J.R. Ocular toxoplasmosis I: parasitology, epidemiology and public health. Clin. Exp. Ophthalmol. 2013, 41:82-94.
34. Gallego C., Saavedra-Matiz C., Gomez-Marin J.E. Direct genotyping of animal and human isolates of Toxoplasma gondii from Colombia (South America). Acta Trop. 2006, 97:161-167.
35. Garweg J.G., Kuenzli H., Boehnke M. Experimental ocular toxoplasmosis in naive and primed rabbits. Ophthalmologica 1998, 212:136-141.
36. Garweg J.G., de Kozak Y., Goldenberg B., Boehnke M. Anti-retinal autoantibodies in experimental ocular and systemic toxoplasmosis. Graefes Arch. Clin. Exp. Ophthalmol. 2009, 248:573-584.
37. Garweg J.G., Stanford M.R. Therapy for Ocular Toxoplasmosis - the Future. Ocul. Immunol. Inflamm. 2013, 21:300-305.
38. Gazzinelli R.T., Brezin A., Li Q., Nussenblatt R.B., Chan C.C. Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-alpha and IFN-gamma. Exp. Parasitol. 1994, 78:217-229.
39. Gilbert R.E., Dunn D.T., Lightman S., Murray P.I., Pavesio C.E., Gormley P.D., Masters J., Parker S.P., Stanford M.R. Incidence of symptomatic Toxoplasma eye disease: aetiology and public health implications. Epidemiol. Infect. 1999, 123:283-289.
40. Gilbert R.E., Freeman K., Lago E.G., Bahia-Oliveira L.M., Tan H.K., Wallon M., Buffolano W., Stanford M.R., Petersen E. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl. Trop. Dis. 2008, 2:e277.
41. Glasner P.D., Silveira C., Kruszon-Moran D., Martins M.C., Burnier Junior M., Silveira S., Camargo M.E., Nussenblatt R.B., Kaslow R.A., Belfort Junior R. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am. J. Ophthalmol. 1992, 114:136-144.
42. Gomez-Diaz E., Jorda M., Peinado M.A., Rivero A. Epigenetics of host-pathogen interactions: the road ahead and the road behind. PLoS Pathog. 2012, 8:e1003007.
43. Gomez-Marin J.E., De-la-Torre A., Angel-Muller E., Rubio J., Arenas J., Osorio E., Nunez L., Pinzon L., Mendez-Cordoba L.C., Bustos A., De-la-Hoz I., Silva P., Beltran M., Chacon L., Marrugo M., Manjarres C., Baquero H., Lora F., Torres E., Zuluaga O.E., Estrada M., Moscote L., Silva M.T., Rivera R., Molina A., Najera S., Sanabria A., Ramirez M.L., Alarcon C., Restrepo N., Falla A., Rodriguez T., Castano G. First Colombian multicentric newborn screening for congenital toxoplasmosis. PLoS Negl. Trop. Dis. 2011, 5:e1195.
44. Gomez-Marin J.E., De-la-Torre A., Barrios P., Cardona N., Alvarez C., Herrera C. Toxoplasmosis in military personnel involved in jungle operations. Acta Trop. 2012, 122:46-51.
45. Gormley P.D., Pavesio C.E., Luthert P., Lightman S. Retinochoroiditis is induced by oral administration of Toxoplasma gondii cysts in the hamster model. Exp. Eye Res. 1999, 68:657-661.
46. Grigg M.E., Ganatra J., Boothroyd J.C., Margolis T.P. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J. Infect. Dis. 2001, 184:633-639.
47. Guerina N.G., Hsu H.W., Meissner H.C., Maguire J.H., Lynfield R., Stechenberg B., Abroms I., Pasternack M.S., Hoff R., Eaton R.B., et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N. Engl. J. Med. 1994, 330:1858-1863.
48. Havelaar A.H., Kemmeren J.M., Kortbeek L.M. Disease burden of congenital toxoplasmosis. Clin. Infect. Dis. 2007, 44:1467-1474.
49. Hodge W.G., Seiff S.R., Margolis T.P. Ocular opportunistic infection incidences among patients who are HIV positive compared to patients who are HIV negative. Ophthalmology 1998, 105:895-900.
50. Holland G.N., O'Connor G.R., Diaz R.F., Minasi P., Wara W.M. Ocular toxoplasmosis in immunosuppressed nonhuman primates. Invest. Ophthalmol. Vis. Sci. 1988, 29:835-842.
51. Holland G.N. Ocular toxoplasmosis: new directions for clinical investigation. Ocul. Immunol. Inflamm. 2000, 8:1-7.
52. Holland G.N. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am. J. Ophthalmol. 2003, 136:973-988.
53. Holland G.N. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am. J. Ophthalmol. 2004, 137:1-17.
54. Holland G.N. Ocular toxoplasmosis: the influence of patient age. Mem. Inst. Oswaldo Cruz 2009, 104:351-357.
55. Horai R., Caspi R.R. Cytokines in autoimmune uveitis. J. Interferon Cytokine Res. 2011, 31:733-744.
56. Jakob E., Reuland M.S., Mackensen F., Harsch N., Fleckenstein M., Lorenz H.M., Max R., Becker M.D. Uveitis subtypes in a german interdisciplinary uveitis center-analysis of 1916 patients. J. Rheumatol. 2009, 36:127-136.
57. Jamieson S.E., de Roubaix L.A., Cortina-Borja M., Tan H.K., Mui E.J., Cordell H.J., Kirisits M.J., Miller E.N., Peacock C.S., Hargrave A.C., Coyne J.J., Boyer K., Bessieres M.H., Buffolano W., Ferret N., Franck J., Kieffer F., Meier P., Nowakowska D.E., Paul M., Peyron F., Stray-Pedersen B., Prusa A.R., Thulliez P., Wallon M., Petersen E., McLeod R., Gilbert R.E., Blackwell J.M. Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. PLoS ONE 2008, 3:e2285.
58. Jamieson S.E., Peixoto-Rangel A.L., Hargrave A.C., Roubaix L.A., Mui E.J., Boulter N.R., Miller E.N., Fuller S.J., Wiley J.S., Castellucci L., Boyer K., Peixe R.G., Kirisits M.J., Elias Lde S., Coyne J.J., Correa-Oliveira R., Sautter M., Smith N.C., Lees M.P., Swisher C.N., Heydemann P., Noble A.G., Patel D., Bardo D., Burrowes D., McLone D., Roizen N., Withers S., Bahia-Oliveira L.M., McLeod R., Blackwell J.M. Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis. Genes Immun. 2010, 11:374-383.
59. Jones J.L., Holland G.N. Annual burden of ocular toxoplasmosis in the US. Am. J. Trop. Med. Hyg. 2010, 82:464-465.
60. Jones L.A., Alexander J., Roberts C.W. Ocular toxoplasmosis: in the storm of the eye. Parasite Immunol. 2006, 28:635-642.
61. Khan A., Jordan C., Muccioli C., Vallochi A.L., Rizzo L.V., Belfort R., Vitor R.W., Silveira C., Sibley L.D. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg. Infect. Dis. 2006, 12:942-949.
62. Kikumura A., Ishikawa T., Norose K. Kinetic analysis of cytokines, chemokines, chemokine receptors and adhesion molecules in murine ocular toxoplasmosis. Br. J. Ophthalmol. 2012, 96:1259-1267.
63. Knight B.C., Brunton C.L., Modi N.C., Wallace G.R., Stanford M.R. The effect of Toxoplasma gondii infection on expression of chemokines by rat retinal vascular endothelial cells. J. Neuroimmunol. 2005, 160:41-47.
64. Knight B.C., Kissane S., Falciani F., Salmon M., Stanford M.R., Wallace G.R. Expression analysis of immune response genes of Muller cells infected with Toxoplasma gondii. J. Neuroimmunol. 2006, 179:126-131.
65. Kong J.T., Grigg M.E., Uyetake L., Parmley S., Boothroyd J.C. Serotyping of Toxoplasma gondii infections in humans using synthetic peptides. J. Infect. Dis. 2003, 187:1484-1495.
66. Lahmar I., Abou-Bacar A., Abdelrahman T., Guinard M., Babba H., Ben Yahia S., Kairallah M., Speeg-Schatz C., Bourcier T., Sauer A., Villard O., Pfaff A.W., Mousli M., Garweg J.G., Candolfi E. Cytokine profiles in toxoplasmic and viral uveitis. J. Infect. Dis. 2009, 199:1239-1249.
67. Lahmar I., Guinard M., Sauer A., Marcellin L., Abdelrahman T., Roux M., Mousli M., Moussa A., Babba H., Pfaff A.W., Candolfi E. Murine neonatal infection provides an efficient model for congenital ocular toxoplasmosis. Exp. Parasitol. 2010, 124:190-196.
68. Lang C., Hildebrandt A., Brand F., Opitz L., Dihazi H., Luder C.G. Impaired chromatin remodelling at STAT1-regulated promoters leads to global unresponsiveness of Toxoplasma gondii-Infected macrophages to IFN-gamma. PLoS Pathog. 2012, 8:e1002483.
69. Leng J., Butcher B.A., Egan C.E., Abi Abdallah D.S., Denkers E.Y. Toxoplasma gondii prevents chromatin remodeling initiated by TLR-triggered macrophage activation. J. Immunol. 2009, 182:489-497.
70. Leng J., Denkers E.Y. Toxoplasma gondii inhibits covalent modification of histone H3 at the IL-10 promoter in infected macrophages. PLoS ONE 2009, 4:e7589.
71. Lindsay D.S., Dubey J.P. Toxoplasma gondii: the changing paradigm of congenital toxoplasmosis. Parasitology 2011, 1-3.
72. Lu F., Huang S., Hu M.S., Kasper L.H. Experimental ocular toxoplasmosis in genetically susceptible and resistant mice. Infect. Immun. 2005, 73:5160-5165.
73. Lyons R.E., Anthony J.P., Ferguson D.J., Byrne N., Alexander J., Roberts F., Roberts C.W. Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor beta and a protective role for interleukin-6. Infect. Immun. 2001, 69:2589-2595.
74. Masur H., Jones T.C., Lempert J.A., Cherubini T.D. Outbreak of toxoplasmosis in a family and documentation of acquired retinochoroiditis. Am. J. Med. 1978, 64:396-402.
75. Mets M.B., Holfels E., Boyer K.M., Swisher C.N., Roizen N., Stein L., Stein M., Hopkins J., Withers S., Mack D., Luciano R., Patel D., Remington J.S., Meier P., McLeod R. Eye manifestations of congenital toxoplasmosis. Am. J. Ophthalmol. 1996, 122:309-324.
76. Mimura K.K., Tedesco R.C., Calabrese K.S., Gil C.D., Oliani S.M. The involvement of anti-inflammatory protein, annexin A1, in ocular toxoplasmosis. Mol. Vis. 2012, 18:1583-1593.
77. Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363:1965-1976.
78. Morisset S., Peyron F., Lobry J.R., Garweg J., Ferrandiz J., Musset K., Gomez-Marin J.E., de la Torre A., Demar M., Carme B., Mercier C., Garin J.F., Cesbron-Delauw M.F. Serotyping of Toxoplasma gondii: striking homogeneous pattern between symptomatic and asymptomatic infections within Europe and South America. Microbes Infect. 2008, 10:742-747.
79. Norose K., Kikumura A., Luster A.D., Hunter C.A., Harris T.H. CXCL10 is required to maintain T-cell populations and to control parasite replication during chronic ocular toxoplasmosis. Invest. Ophthalmol. Vis. Sci. 2011, 52:389-398.
80. Pavesio C.E., Chiappino M.L., Gormley P., Setzer P.Y., Nichols B.A. Acquired retinochoroiditis in hamsters inoculated with ME 49 strain Toxoplasma. Invest. Ophthalmol. Vis. Sci. 1995, 36:2166-2175.
81. Peixoto-Rangel A.L., Miller E.N., Castellucci L., Jamieson S.E., Peixe R.G., Elias Lde S., Correa-Oliveira R., Bahia-Oliveira L.M., Blackwell J.M. Candidate gene analysis of ocular toxoplasmosis in Brazil: evidence for a role for toll-like receptor 9 (TLR9). Mem. Inst. Oswaldo Cruz 2009, 104:1187-1190.
82. Petersen E., Kijlstra A., Stanford M. Epidemiology of ocular toxoplasmosis. Ocul. Immunol. Inflamm. 2012, 20:68-75.
83. Phan L., Kasza K., Jalbrzikowski J., Noble A.G., Latkany P., Kuo A., Mieler W., Meyers S., Rabiah P., Boyer K., Swisher C., Mets M., Roizen N., Cezar S., Sautter M., Remington J., Meier P., McLeod R. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am. J. Ophthalmol. 2008, 146:375-384.
84. Pifer R., Yarovinsky F. Innate responses to Toxoplasma gondii in mice and humans. Trends Parasitol. 2011, 27:388-393.
85. Pivetti-Pezzi P., Accorinti M., Tamburi S., Ciapparoni V., Abdulaziz M.A. Clinical features of toxoplasmic retinochoroiditis in patients with acquired immunodeficiency syndrome. Ann. Ophthalmol. 1994, 26:73-84.
86. Pomares C., Ajzenberg D., Bornard L., Bernardin G., Hasseine L., Darde M.L., Marty P. Toxoplasmosis and horse meat, France. Emerg. Infect. Dis. 2011, 17:1327-1328.
87. Rodriguez A., Calonge M., Pedroza-Seres M., Akova Y.A., Messmer E.M., D'Amico D.J., Foster C.S. Referral patterns of uveitis in a tertiary eye care center. Arch. Ophthalmol. 1996, 114:593-599.
88. Sauer A., Lahmar I., Scholler M., Villard O., Speeg-Schatz C., Brunet J., Pfaff A., Bourcier T., Candolfi E. Development of murine models of ocular toxoplasmosis and preliminary results of ocular inflammatory transcriptome. J. Fr. Ophtalmol. 2009, 32:742-749.
89. Sauer A., de la Torre A., Gomez-Marin J., Bourcier T., Garweg J., Speeg-Schatz C., Candolfi E. Prevention of retinochoroiditis in congenital toxoplasmosis: Europe versus South America. Pediatr. Infect. Dis. J. 2011, 30:601-603.
90. Sauer A., Pfaff A.W., Villard O., Creuzot-Garcher C., Dalle F., Chiquet C., Pelloux H., Speeg-Schatz C., Gaucher D., Prevost G., Bourcier T., Candolfi E. Interleukin 17A as an effective target for anti-inflammatory and antiparasitic treatment of toxoplasmic uveitis. J. Infect. Dis. 2012, 206:1319-1329.
91. Sauer A., Rochet E., Lahmar I., Brunet J., Sabou M., Bourcier T., Candolfi E., Pfaff A.W. The local immune response to intraocular Toxoplasma re-challenge: less pathology and better parasite control through Treg/Th1/Th2 induction. Int. J. Parasitol. 2013, 43:721-728.
92. Silveira C., Belfort R., Muccioli C., Abreu M.T., Martins M.C., Victora C., Nussenblatt R.B., Holland G.N. A follow-up study of Toxoplasma gondii infection in southern Brazil. Am. J. Ophthalmol. 2001, 131:351-354.
93. Skorich D.N., Chiappino M.L., Nichols B.A. Invasion of the guinea pig conjunctiva by Toxoplasma gondii. Invest. Ophthalmol. Vis. Sci. 1988, 29:1871-1880.
94. Streilein J.W. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr. Opin. Immunol. 1993, 5:428-432.
95. Streilein J.W. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J. Leukoc. Biol. 2003, 74:179-185.
96. Sugita S., Futagami Y., Smith S.B., Naggar H., Mochizuki M. Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor beta. Exp. Eye Res. 2006, 83:1459-1471.
97. Sugita S., Horie S., Nakamura O., Futagami Y., Takase H., Keino H., Aburatani H., Katunuma N., Ishidoh K., Yamamoto Y., Mochizuki M. Retinal pigment epithelium-derived CTLA-2alpha induces TGFbeta-producing T regulatory cells. J. Immunol. 2008, 181:7525-7536.
98. Switaj K., Master A., Borkowski P.K., Skrzypczak M., Wojciechowicz J., Zaborowski P. Association of ocular toxoplasmosis with type I Toxoplasma gondii strains: direct genotyping from peripheral blood samples. J. Clin. Microbiol. 2006, 44:4262-4264.
99. Tan H.K., Schmidt D., Stanford M., Tear-Fahnehjelm K., Ferret N., Salt A., Gilbert R. Risk of visual impairment in children with congenital toxoplasmic retinochoroiditis. Am. J. Ophthalmol. 2007, 144:648-653.
100. Tedesco R.C., Smith R.L., Corte-Real S., Calabrese K.S. Ocular toxoplasmosis in mice: comparison of two routes of infection. Parasitology 2005, 131:303-307.
101. Thiebaut R., Leproust S., Chene G., Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 2007, 369:115-122.
102. Van Grol J., Muniz-Feliciano L., Portillo J.A., Bonilha V.L., Subauste C.S. CD40 induces anti-Toxoplasma gondii activity in nonhematopoietic cells dependent on autophagy proteins. Infect. Immun. 2013, 81:2002-2011.
103. Vasconcelos-Santos D.V., Machado Azevedo D.O., Campos W.R., Orefice F., Queiroz-Andrade G.M., Carellos E.V., Castro Romanelli R.M., Januario J.N., Resende L.M., Martins-Filho O.A., de Aguiar Vasconcelos Carneiro A.C., Almeida Vitor R.W., Caiaffa W.T. Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology 2009, 116(2199-2205):e2191.
104. Vasconcelos-Santos D.V. Ocular manifestations of systemic disease: toxoplasmosis. Curr. Opin. Ophthalmol. 2012, 23:543-550.
105. Villard O., Filisetti D., Roch-Deries F., Garweg J., Flament J., Candolfi E. Comparison of enzyme-linked immunosorbent assay, immunoblotting, and PCR for diagnosis of toxoplasmic chorioretinitis. J. Clin. Microbiol. 2003, 41:3537-3541.
106. Villena I., Ancelle T., Delmas C., Garcia P., Brezin A.P., Thulliez P., Wallon M., King L., Goulet V. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro. Surveill. 2010, 15.